Sorrento Therapeutics, Inc.
OTC: SRNEQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Henry H. Ji
- Employees
- 949
- Headquarters
- San Diego, United States
- IPO year
- 2007
- Market cap
- $16.5M
- Website
- https://www.sorrentotherapeutics.com
Loading SRNEQ…
Loading profile data…Frequently asked questions about SRNEQ
What does Sorrento Therapeutics, Inc. (SRNEQ) do?
Sorrento Therapeutics, Inc. is a biopharmaceutical firm that has both clinical-stage and commercial products. It concentrates on developing cutting-edge therapies across three main health domains: oncology, infectious diseases, and pain management. The company is organized into two primary divisions: Sorrento Therapeutics and Scilex. For cancer...
Where does SRNEQ trade?
Sorrento Therapeutics, Inc. (SRNEQ) trades on the Other OTC.
What sector is SRNEQ in?
Sorrento Therapeutics, Inc. (SRNEQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sorrento Therapeutics, Inc.?
Henry H. Ji is the chief executive officer of Sorrento Therapeutics, Inc. (SRNEQ).
Where is Sorrento Therapeutics, Inc. headquartered?
Sorrento Therapeutics, Inc. is headquartered in United States.
Does SRNEQ pay a dividend?
Sorrento Therapeutics, Inc. (SRNEQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SRNEQ go public?
Sorrento Therapeutics, Inc. (SRNEQ) completed its initial public offering in 2007.